At bit.bio discovery, we combine industry-defining iPSC models with unbiased functional genomic CRISPR (knock-out/activation/interference) screening and single cell transcriptomic read-outs to query human biology at single cell resolution. Our technology platform has applications in drug target discovery and validation, drug mechanism of action studies, disease modelling, and variant-to-gene mapping.